|
Re: Comments re AHA presentation
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 07:17PM
|
|
Re: What we know and what we don't.....
|
6
|
Resverlogix Corp.
|
May 16, 2019 04:49PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 03:54PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 02:55PM
|
|
Re: balancing success and failure
|
6
|
Resverlogix Corp.
|
Nov 19, 2019 10:37PM
|
|
SARS-CoV-2 and BRD interactions
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 05:56PM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
6
|
Resverlogix Corp.
|
Jul 03, 2019 12:19PM
|
|
Re: Alzheimer's news
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 04:14PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
6
|
Resverlogix Corp.
|
Jan 08, 2019 04:24PM
|
|
Re: balancing success and failure
|
6
|
Resverlogix Corp.
|
Nov 20, 2019 12:38PM
|
|
Re: Useful review on epigenetics and CKD for the scientists
|
6
|
Resverlogix Corp.
|
Nov 25, 2019 11:50AM
|
|
Re: BRD2 involvement in Covid19
|
6
|
Resverlogix Corp.
|
Mar 18, 2020 12:28PM
|
|
Re: Random thoughts RVX-208 and COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2020 09:47PM
|
|
Re: Contest
|
7
|
Resverlogix Corp.
|
Sep 16, 2019 12:35PM
|
|
Re: Dear Dr. Shokat -- Received a reply !!
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 03:54PM
|
|
Re: Dear Dr. Shokat -- Received a reply !!
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 04:07PM
|
|
Re: Righting the (underpowered) vessel
|
7
|
Resverlogix Corp.
|
Oct 31, 2019 05:43PM
|
|
Re: EDITRe: i would love to hear,..
|
7
|
Resverlogix Corp.
|
Dec 06, 2019 01:04PM
|
|
Re: If BP buys Apabetalone,...
|
7
|
Resverlogix Corp.
|
Nov 06, 2019 12:30PM
|
|
Re: A New Frontier in CV Risk Reduction for Patients With Type 2 Diabetes
|
7
|
Resverlogix Corp.
|
Dec 17, 2018 11:48AM
|
